Bank of New York Mellon’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32M Sell
599,778
-40,255
-6% -$2.18M 0.01% 1338
2026
Q1
$35.9M Sell
640,033
-13,687
-2% -$785K 0.01% 1200
2025
Q4
$35.4M Sell
653,720
-273,347
-29% -$13.9M 0.01% 1220
2025
Q3
$44.7M Buy
927,067
+143,961
+18% +$7.34M 0.01% 1095
2025
Q2
$38.8M Buy
+783,106
New +$39.5M 0.01% 1148

Other funds holding AMRZ

Bank of New York Mellon's AMRZ Position: Q2 2026 in Review

Bank of New York Mellon reduced its Amrize Ltd (AMRZ) stake by 6.3% in Q2 2026, selling an estimated $2.18M and leaving 599,778 shares worth $32M. The position accounts for 0.01% of the portfolio, ranked #1338.

Bank of New York Mellon first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $44.7M in Q3 2025. 226 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

  • Bank of New York Mellon held 599,778 shares of Amrize Ltd worth $32M as of Q2 2026.
  • Bank of New York Mellon sold 40,255 Amrize Ltd shares in Q2 2026, an estimated $2.18M.
  • Amrize Ltd made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1338 holding.
  • Bank of New York Mellon first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
  • Bank of New York Mellon's Amrize Ltd position peaked at $44.7M in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.